Skip to content

Service 04 — Tax planning

Pay what the law intends, not what habit costs

China’s tax code rewards companies that qualify properly. We build the eligibility evidence, document the related-party position and keep the file ready for the day someone asks.

  • HNTE 15%
  • R&D super deduction
  • Transfer pricing files
  • Treaty access

Engagement at a glance

Health check
2–3 weeks
HNTE application
3–5 months
Transfer pricing file
4–8 weeks
Advisory retainer
Monthly
Filing support
Included

Tax positions are documented before they are filed; every recommendation states the risk if challenged.

01

Overview

Planning is documentation, not arithmetic

Almost every China tax benefit reduces to the same question: can you prove the facts that the rule requires? Companies that can, pay materially less. Companies that cannot, pay the difference years later with interest.

A typical foreign-invested company leaves money on the table in three places: it never applies for high and new technology status because nobody owns the file; it claims an R&D deduction without the project registers that support it; and it prices intra-group services on a round number with no benchmarking behind it.

We fix all three, in that order, because the first funds the second and the second is worthless without the third. Where a structure is genuinely aggressive, we say so, quantify the downside and let you decide — an adviser who only tells you what you want to hear is not an adviser.

Where the money usually is

  • HNTE status never applied for, or lapsed at review
  • R&D spend deducted at 100% without project registers
  • Related-party service fees with no benchmarking
  • Dividends distributed at 10% instead of a 5% treaty rate
  • Loss-making years with no contemporaneous file
  • Reinvestment deferral available but not claimed

Our position

We do not sell schemes. Every recommendation is a position with statutory authority, supporting evidence and a stated downside if the authority disagrees.

02

Rates and incentives

The China tax landscape at a glance

Headline rates for the taxes that affect a foreign-invested company. Eligibility is always fact-specific; the table is a map, not advice.

Tax or incentiveRateConditions
Standard corporate income tax25%Every resident enterprise
High and new technology enterprise (HNTE)15%Core IP ownership, R&D intensity and revenue tests
Small and low-profit enterpriseEffective 5%Taxable income up to RMB 3 million, policy to 2027
R&D expense super deduction100%Manufacturing and most service enterprises
Western region and free-trade zones15%Qualifying encouraged industries, location-specific
Qualified software enterprise2 years exempt, 3 years at 12.5%Software products and licensed IP
Dividend withholding (default)10%Distributions to a non-treaty offshore shareholder
Dividend withholding (treaty)5%Hong Kong, Singapore and similar arrangements, subject to beneficial ownership

VAT applies at 13% on goods, 9% on transport, construction and real estate, and 6% on most services; small-scale taxpayers use a 3% levy rate. Individual income tax on employment income is progressive from 3% to 45%. Rates reflect policy in force for 2026 and are reviewed annually.

Rate baseline

The same profit, taxed at four different rates.

Nothing here is a loophole: each lower rate is a status the company has to earn and keep. The work is in qualifying and staying qualified — not in filing a clever form.

Corporate income tax — standard
25%

The default for every resident enterprise without a status.

Dividend repatriation — no treaty
10%

Withholding on profits paid to an offshore parent.

Dividend repatriation — treaty rate
5%

Requires beneficial-ownership substance, not just a Hong Kong shell.

High and new technology enterprise
15%

R&D spend and IP ownership thresholds, re-tested every three years.

Small low-profit enterprise
≈5%

Effective burden on the first RMB 3m of taxable income, subject to headcount and asset tests.

Statutory rates as applied in Beijing for 2026. Eligibility is tested annually from the filed accounts — a status lost in one year is not recovered retroactively.
03

Service scope

Four areas of work

Engaged separately or together. The health check is the usual entry point.

01

Incentive capture

We test your activity against the incentive catalogue, then do the work that actually converts a theoretical benefit into a ruling: IP ownership, R&D project registers, staff ratios and the application file.

  • HNTE feasibility and application
  • R&D super deduction registers
  • Software enterprise certification
  • Regional incentive eligibility
02

Transfer pricing

Related-party flows between your China entity and the group need a defensible policy, contemporaneous documentation and, ideally, an advance view of how the tax authority will read the margin.

  • Benchmarking and policy design
  • Master file, local file and special issue file
  • Annual related-party reporting forms
  • Audit defence and mutual agreement support
03

Cross-border optimisation

Royalties, service fees, dividends and interest are taxed differently and scrutinised differently. We model the net position and document the commercial substance behind each flow.

  • Dividend withholding and treaty access
  • Royalty and service-fee structuring
  • Reinvestment deferral for distributed profits
  • Foreign exchange and tax alignment
04

Compliance review

A periodic review of positions taken across VAT, CIT, IIT and stamp duty, ranked by exposure and probability — not a 40-page list of theoretical risks.

  • Historical filing health check
  • Invoice and cost-deduction review
  • Payroll and IIT exposure
  • Pre-audit preparation
04

Method

Four stages from exposure to evidence

The deliverable at each stage is a document your board, auditor or bank can read.

  1. 01

    Diagnostic

    We review three years of filings, the related-party flows and the current structure, then rank exposures and opportunities by value and probability.

  2. 02

    Position design

    Each opportunity becomes a documented position: eligibility evidence, computation, filing mechanics and the risk if challenged.

  3. 03

    Implementation

    Applications, amended filings, policy documents and registers are prepared and filed. We do not hand you a memo and wish you luck.

  4. 04

    Annual defence

    Documentation is refreshed each year so that a request for the file is answered in days, not months.

05

Fees

Priced on scope, capped in writing

Tax work is quoted as a fixed fee once the scope is clear. Where an application is refused, we do not charge for a resubmission within the same year.

Tax health check

RMB 12,000one-off

A ranked view of exposure and opportunity across three years.

  • Review of CIT, VAT, IIT and stamp duty filings
  • Related-party flow mapping
  • Exposure register with probabilities
  • Opportunity list with indicative value
  • Two-hour findings session
Enquire
Most requested

Transfer pricing file

from RMB 38,000per year

Contemporaneous documentation that stands up in an enquiry.

  • Functional and risk analysis
  • Benchmarking study
  • Local file and master file
  • Annual related-party forms
  • Policy memorandum for the board
  • One round of audit defence included
Enquire

Retained advisory

RMB 2,600per month

A tax partner on call, with filings reviewed before submission.

  • Review of every filing before submission
  • Unlimited written questions
  • Quarterly position review
  • Annual documentation refresh
  • Inspection support at preferential rates
  • Coordination with your auditor
Enquire

HNTE applications are quoted at RMB 38,000–68,000 depending on the technology field and the state of the IP portfolio. Government fees and official charges are additional and passed through at cost.

06

FAQ

Tax questions, answered without hedging

Facing an enquiry?

Call us before you reply to the inspection notice. The first response usually sets the scope of everything that follows.

+86 400 098 9866

The three levers that matter most are high and new technology enterprise status (15% instead of 25%), the 100% R&D super deduction, and getting the transfer-pricing policy right so the China margin is both defensible and appropriate. Incentives are applied for, not claimed automatically — HNTE requires IP ownership in China, an R&D expense ratio and a technology-product revenue test, and the file is re-examined every three years.

Contemporaneous documentation is required where related-party purchases and sales exceed RMB 200 million, other related-party transactions exceed RMB 40 million, or the entity is loss-making with related-party dealings. In practice, a smaller company should still hold a local file: it is the first thing requested in an enquiry, and the penalty for not having one is separate from any tax adjustment.

Yes, usually to 5%, under a double tax arrangement such as the mainland–Hong Kong or China–Singapore treaty. The reduction is not automatic: the recipient must be the beneficial owner, hold the required equity percentage, and have substance. Applications are filed with the withholding agent at the time of distribution, and retrospective claims are possible but far slower.

Arranging your affairs to qualify for incentives the law provides is legitimate and encouraged. What is not permitted is creating a structure without commercial substance purely to obtain a tax benefit — the tax authority can disregard it under the general anti-avoidance rules. Our work always documents the business rationale first and the tax outcome second.

A foreign investor that reinvests distributed profits directly into a encouraged project in China can defer the 10% withholding tax on that dividend, provided the funds stay invested for at least five years. It is one of the few incentives available to the offshore shareholder rather than the Chinese company, and the application must be made through the tax authority before the distribution.

Inspection risk rises with three things: sustained losses with growing revenue, related-party flows that do not match a documented policy, and invoice patterns that differ from industry norms. A review tells you where you sit on those three axes and what a defensible file looks like before anyone asks.

Yes. We prepare the position paper, assemble the supporting evidence, and attend meetings with the inspection team. Our role is usually to narrow the dispute to specific transactions rather than to argue the whole assessment, which is how adjustments get reduced.

HNTE status attaches to the legal entity, not the shareholders, so an equity transfer does not by itself remove it — but the substantive tests are re-run at each three-year review, and a change of business substance can fail them. Dividend treaty benefits, by contrast, depend on the new shareholder’s residence and substance.

Next step

Find out what your China entity is leaving on the table

Send your latest annual CIT return and a list of intra-group payments. We will come back with the two or three positions worth pursuing, and what they are worth.

Call us directly

+86 400 098 9866info@bcac.com.cn

Mon–Fri 09:00–18:00 · Sat by appointment